Article Sidebar
Published:
Jan 12, 2017Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Physical characterization and kinetic modelling of matrix tablets of ketorolac tromethamol formulated with polymers and waxes
Abstract
Purpose: To design controlled release ketorolac tromethamol (KT) matrix tablets for increased drug bioavailability.
Methods: Waxes (Compritol® ATO 888, Precirol® ATO 5 and stearic acid - SA) and polymers (hydroxypropyl methylcellulose - HPMC and xanthan gum - XG) were used in the preparation of the matrix tablets at various excipient concentrations for controlled drug delivery. The physical properties of the formulations were determined. Drug release profiles from the tablets were obtained and their drug release mechanisms were characterized by kinetic modeling. Analytical quantification method of KT in dissolution media was also validated by certain performance criteria.
Results: KT matrix tablets prepared individually with Compritol and HPMC at 30 and 40 % concentrations, respectively, displayed the best tablet compression properties. The tablets prepared with HPMC and XG displayed slower drug release profiles compared to the tablets prepared with waxes in general (p < 0.05). KT release increased with increase in pH since it is a weak acid (p < 0.05). Statistically insignificant difference was observed among all the tablets prepared with HPMC and XG in water (p > 0.05). However, drug release from the tablets containing 40 % XG was faster than tablets prepared with HPMC (30 and 40 %) and XG (30 %) at pH 7.2 (p < 0.05). Drug release mechanisms from the tablets prepared with wax and polymers were non-Fickian, indicating coupled diffusion/erosion and diffusion/polymer relaxation, respectively.
Conclusion: KT matrix tablets have been successfully formulated by direct compression method. The findings demonstrate that both the desired physical characteristics and drug release profiles were obtained for matrix tablets prepared with HPMC.
Keywords: Ketorolac tromethamol, Controlled release, Matrix tablets, Oral drug delivery, Waxes, Polymers
